IDEX Co. (NYSE:IEX) Shares Sold by Xponance Inc.

Xponance Inc. decreased its holdings in IDEX Co. (NYSE:IEX) by 1.2% in the 4th quarter, HoldingsChannel reports. The firm owned 10,304 shares of the industrial products company’s stock after selling 124 shares during the quarter. Xponance Inc.’s holdings in IDEX were worth $2,157,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently modified their holdings of the company. Jones Financial Companies Lllp lifted its stake in IDEX by 35.2% in the 4th quarter. Jones Financial Companies Lllp now owns 407 shares of the industrial products company’s stock worth $85,000 after acquiring an additional 106 shares in the last quarter. Brooklyn Investment Group acquired a new stake in IDEX in the 3rd quarter valued at approximately $86,000. Assetmark Inc. grew its holdings in IDEX by 129.1% in the 4th quarter. Assetmark Inc. now owns 417 shares of the industrial products company’s stock valued at $87,000 after buying an additional 235 shares during the last quarter. Fred Alger Management LLC acquired a new stake in IDEX in the 3rd quarter valued at approximately $89,000. Finally, Millburn Ridgefield Corp grew its holdings in shares of IDEX by 475.0% during the 3rd quarter. Millburn Ridgefield Corp now owns 460 shares of the industrial products company’s stock worth $99,000 after purchasing an additional 380 shares in the last quarter. Institutional investors own 97.96% of the company’s stock.

IDEX Trading Down 0.9 %

IEX stock opened at $182.02 on Friday. The company has a market cap of $13.79 billion, a P/E ratio of 27.37, a PEG ratio of 1.98 and a beta of 0.99. IDEX Co. has a twelve month low of $177.71 and a twelve month high of $246.36. The company has a quick ratio of 1.85, a current ratio of 2.53 and a debt-to-equity ratio of 0.49. The business has a fifty day moving average of $200.23 and a 200-day moving average of $209.82.

IDEX (NYSE:IEX) last announced its quarterly earnings data on Tuesday, February 4th. The industrial products company reported $2.04 EPS for the quarter, topping analysts’ consensus estimates of $2.03 by $0.01. IDEX had a return on equity of 16.08% and a net margin of 15.45%. As a group, equities research analysts expect that IDEX Co. will post 8.26 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on IEX shares. Royal Bank of Canada decreased their price objective on IDEX from $256.00 to $245.00 and set an “outperform” rating on the stock in a report on Thursday, February 6th. Stifel Nicolaus lifted their price objective on IDEX from $244.00 to $256.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. DA Davidson cut their target price on IDEX from $225.00 to $215.00 and set a “neutral” rating for the company in a research report on Wednesday, February 19th. Finally, Citigroup cut their target price on IDEX from $269.00 to $267.00 and set a “buy” rating for the company in a research report on Monday, January 13th. Three analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $241.71.

About IDEX

IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, valves, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries.